XT
AIDX

XTX Topco’s 20/20 Biolabs Inc AIDX Stock Holding History

XTX Topco’s Portfolio AIDX Stock Details AIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4K Buy
+10,329
New +$43.6K ﹤0.01% 3554

Other funds holding AIDX

CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

XTX Topco's AIDX Position: Q1 2026 in Review

XTX Topco opened a new position in 20/20 Biolabs Inc (AIDX) in Q1 2026: 10,329 shares worth $19.4K. The stake represents ﹤0.01% of the portfolio and ranks #3554 among its holdings.

7 funds tracked by Wall St. Rank hold AIDX as of Q1 2026.

  • XTX Topco held 10,329 shares of 20/20 Biolabs Inc worth $19.4K as of Q1 2026.
  • 20/20 Biolabs Inc was a new XTX Topco position in Q1 2026.
  • 20/20 Biolabs Inc made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3554 holding.
  • 7 funds tracked by Wall St. Rank held 20/20 Biolabs Inc as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.